Drugs are not inherently bad but this comes at a high cost with dubious efficacy: - $1,500-3,000 in annual out-of-pocket costs per person - 1.5M ER visits yearly from adverse drug interactions - Higher risks of kidney, liver and other bodily injuries For #healthcare founders and operators, theres an important opportunity to improve lives while bringing down costs for everyone
doi: 10.1371/journal.pone.0085387 501 KerrJR
A notable example is Petasites japonicus-derived EVs (PJ-EVs), which significantly promote dendritic cell (DC) maturation by upregulating surface markers (CD80, CD86, MHC-I, MHC-II), enhancing Th1-polarizing cytokine secretion (TNF-, IL-12p70), and improving antigen presentation capacity while reducing antigen uptake
Figure 3 3.4 Effects of kaempferol on antioxidant-related indicators in serum of late-laying hens As shown in Figure 4, compared with the CON group, the 0.4 and 0.6 g/kg KAE groups significantly increased the serum glutathione peroxidase (GSH-PX) activity of late laying hens ( p 0.05)
Great level of after care and Im a 100% happy customer
